Clinical Trials

Last updated Tue, 13 May 2008 04:08:26 -0500.

Nephritis

• Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
• Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
• A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
• Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old

Hypertension

• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
• Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension: ACCOMPLISH
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• Diuretics In the Management of Essential Hypertension (DIME) Study
• Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
• To Assess the Effect of Naproxcinod vs. Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension
• A Phase 2, Pharmacokinetic Study of the Effects of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Poorly Controlled Essential Hypertension
• Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension
• Comparison of the Efficacy and Safety of TAK-491 With Valsartan in Subjects With Essential Hypertension
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
• Olmesartan in Essential Hypertension
• Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
• Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
• Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
• Heart Rate Variability in White Coat Hypertension and Essential Hypertension
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
• Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
• Evaluation of the Efficacy and Safety of TAK-491 Co-Administered With Amlodipine in Subjects With Essential Hypertension
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• Evaluation of the Efficacy and Safety of TAK-491 in Black Subjects With Essential Hypertension
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
• Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
• L-Arginine Metabolism in Essential Hypertension
• Uric Acid in Essential Hypertension in Children
• A 54 Week, Randomized, Double-Blind, Parallel-Group, Multicenter Study Evaluating the Long-Term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension
• Study to Determine the Efficacy of Perindopril to Prevent the Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
• Diuretics In the Management of Essential Hypertension (DIME) Study
• Evaluation of the Efficacy and Safety of TAK-491 Co-Administered With Chlorthalidone in Subjects With Essential Hypertension
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
• A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• Comparison of Awakening vs. Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
• Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
• Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
• Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
• The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension
• The Renin-Angiotensin System in Essential Hypertension
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
• Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
• Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan and #174;-Induced Flushing in Subjects With Dyslipidemia
• CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
• A Phase III, Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Multiple Fixed-Dose Study of MCI-196 Versus Placebo With Hyperphosphatemia and Dyslipidaemia
• An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• A 54 Week, Randomized, Double-Blind, Parallel-Group, Multicenter Study Evaluating the Long-Term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension
• Uric Acid in Essential Hypertension in Children
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
• Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension
• Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
• Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
• Research Study To Test Coreg CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
• Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension
• Heart Rate Variability in White Coat Hypertension and Essential Hypertension
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
• Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
• A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension
• To Assess the Effect of Naproxcinod vs. Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension

Nephrology

• Studies of Organ Transplantation in Animals and Man
• Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
• Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients
• Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A
• 5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients
• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
• Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
• Influence of Pioglitazone for Renal Transplant Function in Diabetics
• Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients
• Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection
• Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure
• Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
• Cranoc Lipid Study in Renal Transplantation
• Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes
• Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
• The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
• The Effect of a Coordinated Inpatient Diabetes Education Program in the Outpatient Setting
• Intranasal Insulin for Prevention of Type 1 Diabetes
• The Diabetes TeleCare Study
• Obesity and Diabetes Prevention Through Science Enrichment
• Improving Diabetes Quality of Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse
• DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
• Remote Monitoring in Diabetes Disease Management
• GLYCOSA Study:Effect of PAP Treatment on Glycaemic Control in Patients With Type 2 Diabetes
• The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
• Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
• Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus Not Previously Treated With Drug Therapy, and the Effects of Colesevelam HCl on Lipids (e.g., Cholesterol) and Glucose
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
• Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
• Prospective Assessment in Newborns for Diabetes Autoimmunity
• Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills
• A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease
• Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
• Diabetes Prevention Program in Schizophrenia [DPPS]
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
• Obese Patients With Type 2 Diabetes
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
• VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients
• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
• A Study Evaluating Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
• Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
• Prediction of NODAT After Renal Transplantation
• Prevention of Relapses in Proteinase 3 (PR3)-Anti-Neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes
• Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
• Improved Delivery of Cardiovascular Care Through Outreach Facilitation
• Epoetin Dosing Regimens in Haemodialysis
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
• Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
• Biological Markers in Retinal Vasculitis
• Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension: ACCOMPLISH
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
• StaphVAX in Cardiovascular Surgery Patients
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Etanercept to Treat Wegener's Granulomatosis
• Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness
• Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
• Steroids and Methotrexate to Treat Systemic Vasculitis
• Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
• Effects of Black Tea on Cardiovascular Disease in the Mauritian Population
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
• Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
• Determining Disease Activity Biomarkers in Individuals With Wegener's Granulomatosis and Microscopic Polyangiitis
• Cardiovascular Risk Factors in an Ambulatory Urban Patient Population
• CellCept in p-ANCA Vasculitis
• Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
• Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
• Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
• CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
• Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis
• Safety and Efficacy Study Comparing ABT-335 in Combination With Atorvastatin and Ezetemibe to Atorvastatin in Combination With Ezetemibe in Subjects With Abnormal Lipid (Fat) Levels in the Blood
• Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
• Technical Development of Cardiovascular Magnetic Resonance Imaging
• Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-Related Vasculitis Patients
• Oxidative Stress and Cardiovascular Morbidity in SAHS
• A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
• Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
• Determining Disease Activity Biomarkers in Individuals With Churg-Strauss Syndrome
• Cardiovascular Longitudinal Evaluation and amp; Assessment of Risk (CLEAR) Study
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
• A Study of the Efficacy and Safety of Enteric-Coated Aspirin in Patients at Moderate Risk of Cardiovascular Disease
• Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
• Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
• Assessment of Patients With Multiple Sclerosis (MS)

Diabetes

• Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
• Influence of Pioglitazone for Renal Transplant Function in Diabetics
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
• Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus Not Previously Treated With Drug Therapy, and the Effects of Colesevelam HCl on Lipids (e.g., Cholesterol) and Glucose
• Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
• Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills
• Prospective Assessment in Newborns for Diabetes Autoimmunity
• A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease
• Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
• Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
• Diabetes Prevention Program in Schizophrenia [DPPS]
• Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment
• Obese Patients With Type 2 Diabetes
• Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes
• The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
• Intranasal Insulin for Prevention of Type 1 Diabetes
• The Effect of a Coordinated Inpatient Diabetes Education Program in the Outpatient Setting
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Obesity and Diabetes Prevention Through Science Enrichment
• The Diabetes TeleCare Study
• DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
• Improving Diabetes Quality of Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse
• GLYCOSA Study:Effect of PAP Treatment on Glycaemic Control in Patients With Type 2 Diabetes
• Remote Monitoring in Diabetes Disease Management
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
• The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
• A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person
• A Study Evaluating Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
• The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
• The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes
• Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)
• Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
• Obesity and Diabetes Prevention Through Science Enrichment
• Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
• A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease
• Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment
• Diabetes Prevention Program in Schizophrenia [DPPS]
• Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
• Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
• TTA in Treatment of Diabetes and Dyslipidemia
• Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
• Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
• Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
• CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
• Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
• Nitric Oxide (NO) Activity and Diabetic Nephropathy
• Influence of Pioglitazone for Renal Transplant Function in Diabetics
• Effects of Tinzaparin on Cardio-Vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis
• Effect of Pulsing Electrical Fields on Lower Extremity Diabetic Neuropathy: A Pilot, Open-Label Study
• Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
• LOADD (Lifestyle Over and Above Drugs in Diabetes) Study
• Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
• T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus
• Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 Diabetes
• The Diabetes TeleCare Study
• Obesity and Diabetes Prevention Through Science Enrichment
• Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
• Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus Not Previously Treated With Drug Therapy, and the Effects of Colesevelam HCl on Lipids (e.g., Cholesterol) and Glucose
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
• Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
• Natural History Study of the Development of Type 1 Diabetes
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
• A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
• Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
• The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
• Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
• A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
• Feasibility Study of Digital Photography and Group Discussion for People With Diabetes
• Spanish Diabetes Self-Management Program
• Diabetes Prevention Program in Schizophrenia [DPPS]
• Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 and amp; 2 Diabetes
• Internet Diabetes Self-Management
• The Effect of a Coordinated Inpatient Diabetes Education Program in the Outpatient Setting
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
• Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills
• The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 Diabetes
• South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus
• Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment

Dialysis

• 5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients
• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
• Epoetin Dosing Regimens in Haemodialysis
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients
• The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure
• Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Rates of Hospitalization in Home Care Assisted Peritoneal Dialysis
• Resistance Training During Maintenance Dialysis
• Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
• The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
• Very Low Protein Diet or Dialysis in Uremic Elderly?
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
• 5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients
• More Time, Better Outcome - A Trial to Investigate the Effect of More Dietetic Time in Dialysis Patients
• Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
• Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
• Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life
• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
• Effects of Tinzaparin on Cardio-Vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure
• Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
• Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
• Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
• Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls
• Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
• Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis
• Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
• Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
• The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients
• Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
• Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients
• Dialysis Catheter Comparative Clinical Trial
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
• The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure
• Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients
• Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis
• Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
• Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
• Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients
• Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD
• A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
• The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
• Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy
• Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
• FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
• Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
• Vitamin D 2 to Dialysis Patients
• Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure
• Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
• Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
• Very Low Protein Diet or Dialysis in Uremic Elderly?
• Elimination of Protein-Bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
• Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology
• Hannover Dialysis Outcome Study
• A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis
• Rates of Hospitalization in Home Care Assisted Peritoneal Dialysis
• Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
• Longitudinal Evaluation of Volume Status in Peritoneal Dialysis Patients
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
• Resistance Training During Maintenance Dialysis
• Temperature Control During Dialysis Treatment
• Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
• Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
• T-Wave Alternans in Dialysis Patients
• Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath
• Morbidity and Mortality Among Dialysis Patients After Treatment for Depression
• Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
• Glucose in Dialysis Water in Non-Diabetics
• Method of Exit Site Care in Chronic Peritoneal Dialysis Patients
• MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
• STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE
• Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis
• Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin
• Comparison of the Impact of Dialysis Treatment Type on Patient Survival
• Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology
• Frequent Hemodialysis Network: Nocturnal Trial
• Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients
• Dialysate Sodium Individualization in Hemodialysis
• Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
• Comparison of Femoral Versus Jugular Routes for Temporary Hemodialysis in Seriously Ill Patients
• Hemodialysis Without Anticoagulation in Intensive Care Unit
• Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Comparison of Post-Dilution on-Line Hemodiafiltration and Hemodialysis
• The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
• The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure
• Rates of Hospitalization in Home Care Assisted Peritoneal Dialysis
• The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure
• Oxidative Stress and Hemodialysis Access Failure
• Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
• Frequent Hemodialysis Network: Daily Trial

Vasculitis

• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
• Prevention of Relapses in Proteinase 3 (PR3)-Anti-Neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
• Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
• RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
• Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
• Steroids and Methotrexate to Treat Systemic Vasculitis
• Biological Markers in Retinal Vasculitis
• Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis
• Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-Related Vasculitis Patients
• Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
• CellCept in p-ANCA Vasculitis
• WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
• Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
• CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
• Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

Cardiovascular

• Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
• Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus Not Previously Treated With Drug Therapy, and the Effects of Colesevelam HCl on Lipids (e.g., Cholesterol) and Glucose
• GLYCOSA Study:Effect of PAP Treatment on Glycaemic Control in Patients With Type 2 Diabetes
• A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease
• A Study Evaluating Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
• StaphVAX in Cardiovascular Surgery Patients
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness
• Improved Delivery of Cardiovascular Care Through Outreach Facilitation
• A Study of the Efficacy and Safety of Enteric-Coated Aspirin in Patients at Moderate Risk of Cardiovascular Disease
• Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
• Effects of Black Tea on Cardiovascular Disease in the Mauritian Population
• Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
• Cardiovascular Risk Factors in an Ambulatory Urban Patient Population
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
• Avoiding Cardiovascular Events Through COMbination Therapy in Patients Living With Systolic Hypertension: ACCOMPLISH
• Oxidative Stress and Cardiovascular Morbidity in SAHS
• Technical Development of Cardiovascular Magnetic Resonance Imaging
• Cardiovascular Longitudinal Evaluation and amp; Assessment of Risk (CLEAR) Study
• VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients
• Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe
• Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
• Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
• Abuja Heart Study: Prospective Epidemiologic Investigation of Cardiovascular Diseases
• Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment
• The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
• Effect of Apple Flavanols on Risk of Cardiovascular Disease
• HIV and Cardiovascular Risk
• Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)
• Diuretics In the Management of Essential Hypertension (DIME) Study
• A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease